Clinical Trial

Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy

Study acronym: RECLAIM-TNK
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy and safety of intra-arterial TNK bridging therapy following incomplete recanalization (2b ≤ eTICI \< 3) after mechanical thrombectomy for acute anterior circulation large vessel occlusion.
Trial Details
NCT Number NCT07471282
Lead Sponsor Chuansheng Zhao
Conditions Stroke
Enrollment 344 participants
Start Date 2026-03-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-13